Ashwagandha Raw Material Testing: What Your Analytical Laboratory Needs to Verify Before You Accept a Single Kilogram

The US ashwagandha market crossed $130 million in annual retail sales in 2023, and analysts have it on track to grow more than 12% annually through 2028. With that kind of demand pressure, ingredient suppliers in India — where well over 90% of commercial Withania somnifera is cultivated — are working at pace. And when speed collides with margin pressure in the botanical supply chain, quality problems multiply fast.

We’ve processed enough ashwagandha lots through our analytical laboratories to say this plainly: the COA from your supplier is not sufficient documentation. Not even close. Here’s what a proper incoming testing program actually covers, and where the gaps consistently hurt Midwest supplement brands.

Why Ashwagandha Is One of the Highest-Risk Raw Materials in Your Supplier Panel

Every botanical raw material carries some adulteration risk. Ashwagandha concentrates several of them in a single ingredient. It’s sourced almost entirely from one country. Its primary active markers — the withanolides — are genuinely difficult to quantify accurately with simple wet chemistry. And the root, which is the part used in most supplements, is an efficient accumulator of soil-based contaminants including lead and arsenic.

AOAC International’s working group on dietary supplement methods flagged withanolide standardization as an ongoing accuracy problem as recently as 2022. Part of the challenge is that “withanolide” is not a single compound. There are more than 50 withanolide-type structures in W. somnifera, and different analytical methods capture different fractions. A supplier reporting “5% withanolides by HPLC” and another reporting “5% withanolides by UV” are almost certainly measuring different things — and the variance between those two approaches in practice is not small.

Then there’s species substitution. Withania coagulans — a closely related species with similar root morphology but a meaningfully different phytochemical profile — has been documented in commercial ashwagandha supply chains on multiple occasions. Visual inspection of dried root won’t distinguish it. Most standard HPLC methods won’t catch it either unless the method is specifically designed to detect coagulogenol, the marker compound that differentiates the two species.

Species Identity: Why HPTLC and DNA Barcoding Are Both Required

The USP botanical monograph for Withania somnifera root specifies thin-layer chromatography (TLC) as an identification test, and HPTLC — the densitometrically-scanned, quantitative upgrade — is the method now used in most ISO 17025-accredited analytical laboratories running identity testing at scale. A validated HPTLC run against the USP botanical reference standard for W. somnifera confirms the correct chemical fingerprint and will flag W. coagulans substitution, because the withanolide spot pattern is distinct between the two species.

But HPTLC has a real blind spot: it reads chemistry, not genetics. If a shipment contains properly-extracted W. somnifera material mixed with starch, maltodextrin, or modified cellulose bulking agents — not an unheard-of adulterant strategy — the chromatogram may look clean while the lot is 25–35% filler by weight. This is why DNA barcoding, specifically targeting the ITS2 gene region for Withania, is complementary rather than redundant. Together, the two methods catch both chemical substitution and genetic adulteration. Neither alone covers the full risk profile.

Under 21 CFR Part 111.75(a)(1), every dietary ingredient must be positively identified before it can be used in manufacturing. FDA has been explicit in recent warning letters — most recently in a 2024 enforcement action targeting a botanical supplement manufacturer — that visual inspection alone does not satisfy this requirement. Running both HPTLC and DNA barcoding on every incoming ashwagandha shipment is the defensible standard. Any analytical laboratory telling you one method is sufficient should be pressed on that.

Withanolide Content Verification: The Number on Your COA Is Probably Off

Let’s be direct about this. If your ashwagandha COA reports withanolide content by a UV absorbance method — sometimes labeled “colorimetric,” “spectrophotometric,” or simply “USP” without a specific method number — that number is very likely inflated. UV methods based on perchloric acid reaction don’t measure withanolides specifically. They detect a broader class of steroids and include non-withanolide compounds in the count.

A 2019 study published in the Journal of AOAC International compared UV and HPLC results across 44 commercial ashwagandha samples. For lots where the UV method reported 5% withanolides, the actual HPLC-confirmed content averaged 2.8% — a 44% overstatement. That study is now several years old, and supply chain pressures haven’t improved the situation. If anything, growing demand for “standardized” extracts at commodity pricing has made the problem worse.

For Midwest brands selling standardized ashwagandha products — and particularly any product sold through Amazon, where FTC substantiation requirements for structure/function claims are increasingly scrutinized — having a verified HPLC withanolide number on your CoA isn’t optional. It’s the difference between a defensible label claim and an inquiry. Our analytical laboratories run withanolide quantification by HPLC-UV with a specific standard curve built for withaferin A and withanolide D — the two primary markers used in both proprietary extract specifications (KSM-66, Sensoril, Shoden) and in customer-facing label claims.

Three specific COA red flags worth checking right now: the quantification method isn’t identified by name, no reference standard is listed, or the withanolide number exceeds 8% for a root powder (not a concentrated extract). Root powders legitimately standardized above 8% by a validated HPLC method are very rare. Numbers above that threshold by UV are almost certainly noise.

The Heavy Metals Problem Specific to Ashwagandha Root

Withania somnifera is primarily grown in semi-arid Indian soils, many of which carry elevated baseline lead and arsenic concentrations from both natural geology and decades of agricultural input accumulation. The root accumulates soil metals — this is a biological reality of root crop physiology that applies broadly to Ayurvedic botanicals grown in this region.

USP <232> sets the maximum permitted daily exposure for lead in oral botanical supplements at 10 µg/day. At a typical ashwagandha serving size of 600 mg, a raw material with 1 ppm lead contributes 0.6 µg/day — well within limits. But in our incoming testing data, Indian-sourced ashwagandha root regularly arrives at 3–8 ppm lead by ICP-MS. At 600 mg/day and 8 ppm, that’s 4.8 µg/day — still technically compliant with USP <232>, but within range if the consumer is also taking additional supplements or has dietary lead exposure from other sources.

Arsenic is the more acute concern. USP <232> limits inorganic arsenic (the acutely toxic form) to 15 µg/day. Reaching that threshold requires speciated arsenic analysis — a method that separates inorganic As(III) and As(V) from the relatively benign organoarsenicals. The problem is that most standard COAs report only total arsenic. We’ve seen ashwagandha lots arrive with total arsenic at 4–6 ppm where subsequent speciation showed more than 70% inorganic arsenic. At a 600 mg serving, that’s 1.7–2.5 µg/day of inorganic arsenic per serving — not catastrophic, but material if your customer takes 2–3 servings daily or uses multiple botanicals.

Any ISO 17025-accredited analytical laboratory running ashwagandha testing under USP <232>/<233> should be running ICP-MS for at minimum lead, total arsenic (with speciation for high-risk origin material), cadmium, and mercury. If your current testing program only reports total arsenic, you have a gap worth addressing before your next lot release.

What to Require From Your Analytical Laboratory on Every Incoming Shipment

Based on the patterns we observe from Midwest supplement brands — and the gap between current testing programs and what a cGMP-compliant incoming release program actually requires — here’s the minimum checklist for each ashwagandha lot:

Botanical Identity

• HPTLC against the USP Withania somnifera botanical reference standard
• DNA barcoding (ITS2 gene region) confirming W. somnifera

Potency / Marker Compound Verification

• Withanolides by HPLC-UV with identified reference standards (withaferin A and withanolide D at minimum)
• Steroidal alkaloid screening if material originates from non-certified suppliers

Elemental Impurities (ICP-MS per USP <232>/<233>)

• Lead, cadmium, mercury, total arsenic
• Speciated arsenic (inorganic vs. organic) for Indian-origin root material

Microbiological Testing (USP <61>/<62>)

• Total aerobic microbial count (TAMC): ≤ 10⁵ CFU/g per USP <1111> Category 2 limits
• Total yeasts and molds (TYMC): ≤ 10³ CFU/g
• Absence of Salmonella spp. and E. coli per USP <2023>

Pesticide Residue Screening

• Multi-residue panel per USP <561> or equivalent — essential for non-organic-certified Indian agricultural material

That’s five separate test families for a single incoming raw material. The cost of testing a 25 kg lot through this full panel runs roughly $400–$650 at most qualified analytical laboratories. The cost of an FDA warning letter, an Amazon listing suspension, or a product liability claim is categorically different.

Reducing Logistics Friction for Midwest Brands

One friction point we hear consistently from supplement manufacturers in Illinois, Indiana, Wisconsin, and Ohio is the logistics of getting samples to a West Coast or Northeast laboratory without compromising integrity or production timelines. Temperature excursions during two-day ground shipping, delayed sample receipt documentation, and CoA turnarounds that stretch to three weeks create real problems for brands trying to keep raw material release on schedule.

Our Countryside, IL receiving hub was built specifically for this. Samples arrive within overnight or two-day freight from anywhere in the Midwest, are logged under full chain of custody on arrival, and move directly into the ISO 17025-accredited testing pipeline at Qalitex’s California laboratories. A standard ashwagandha incoming panel — identity, potency, heavy metals, and microbiology — typically turns around in 5–7 business days from receipt of sample. For operations teams managing purchase order timelines, that’s a meaningfully different cadence than routing samples cross-country first.

If the logistics piece of your current analytical laboratory relationship is adding cost or uncertainty to your raw material release program, it’s worth asking whether a Midwest-based receiving point changes the math.

---

Pull your last three ashwagandha COAs and check these three things before your next purchase order: the withanolide quantification method (if it doesn’t explicitly say HPLC, the number is likely overstated), whether arsenic is reported as total or speciated, and whether any DNA-based identity confirmation is included. Those three data points will tell you whether your current incoming testing program would hold up under an FDA inspection — or an Amazon supplier audit.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• ISO 17025 Botanical & Raw Material Testing at Qalitex Laboratories — Full-service identity, potency, ICP-MS, and microbiological testing for herbal supplement raw materials under ISO 17025 accreditation